BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30865240)

  • 1. Type 2 diabetes mellitus and risk of cutaneous squamous cell carcinoma.
    Chen ST; Li T; Han J; Qureshi AA; Cho E
    J Am Acad Dermatol; 2016 Oct; 75(4):831-834. PubMed ID: 27646740
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic and transcriptomic analysis of cutaneous squamous cell carcinoma arising in immunocompetent and immunosuppressed patients.
    Bibee KP; Kulkarni A; Lee S; Ho J; Osmanbeyoglu HU; Ferris RL; Zandberg DP
    Oral Oncol; 2024 Jan; 148():106582. PubMed ID: 38039877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk.
    Kim Y; Yin J; Le Breton S; Jorgenson E; Huang H; Choquet H; Asgari MM
    J Invest Dermatol; 2023 Apr; 143(4):664-667. PubMed ID: 36343677
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective study evaluating the personal history of rosacea and risk of cutaneous squamous cell carcinoma among women in the United States.
    Lin EM; Rajadurai S; Qureshi AA; Cho E
    J Am Acad Dermatol; 2022 Dec; 87(6):1389-1391. PubMed ID: 36089188
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequencing before prescription for immunosuppressed patients.
    Zheng S; Lutters B; Verduyn Lunel F
    Lancet; 2023 Oct; 402(10412):1526. PubMed ID: 37898528
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.
    Smith SD; Stratigos A; Augustin M; Carrascosa JM; Grond S; Riedl E; Xu W; Patel H; Lebwohl M
    Dermatol Ther (Heidelb); 2023 Aug; 13(8):1773-1787. PubMed ID: 37351831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.
    Bottomley MJ; Massey PR; Thuraisingham R; Doyle A; Rao S; Bibee KP; Bouwes Bavinck JN; Jambusaria-Pahlajani A; Harwood CA
    Transpl Int; 2022; 35():10880. PubMed ID: 36484063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma.
    McLean LS; Lim AM; Webb A; Cavanagh K; Thai A; Magarey M; Fox C; Kleid S; Rischin D
    Front Oncol; 2021; 11():796197. PubMed ID: 35117997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of advanced cutaneous squamous cell carcinoma.
    de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration.
    Liu Z; Zhang D; Liu C; Li G; Chen H; Ling H; Zhang F; Huang D; Wang X; Liu Y; Zhang X
    Front Immunol; 2021; 12():659184. PubMed ID: 33995379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade.
    Heath BR; Michmerhuizen NL; Donnelly CR; Sansanaphongpricha K; Sun D; Brenner JC; Lei YL
    J Dent Res; 2019 Sep; 98(10):1073-1080. PubMed ID: 31340724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Cutaneous Squamous Cell Carcinoma in Immunosuppressed vs Immunocompetent Patients.
    Gonzalez JL; Reddy ND; Cunningham K; Silverman R; Madan E; Nguyen BM
    JAMA Dermatol; 2019 May; 155(5):625-627. PubMed ID: 30865240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.
    Wang J; Aldabagh B; Yu J; Arron ST
    J Am Acad Dermatol; 2014 Apr; 70(4):621-629. PubMed ID: 24629358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients.
    Genders RE; Osinga JAJ; Tromp EE; O'Rourke P; Bouwes Bavinck JN; Plasmeijer EI
    Acta Derm Venereol; 2018 Jun; 98(6):551-555. PubMed ID: 29405246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.
    Tam S; Gross ND
    Curr Oncol Rep; 2019 Jul; 21(9):82. PubMed ID: 31359288
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.